Danish Marine and Shipping Stock News

Danske Bank has continued its DKK 5.00 billion share buy-back programme, having repurchased 18,155,560 shares so far, while also appointing Dr Fiona Browne as its first Head of AI to lead a new AI centre of excellence in Belfast. Together, the ongoing buy-back and creation of a dedicated AI leadership role highlight Danske Bank’s twin focus on capital return discipline and building in-house technological capabilities. We’ll now examine how the expanding share buy-back and new AI centre of...

Those holding Shape Robotics A/S ( CPH:SHAPE ) shares would be relieved that the share price has rebounded 26% in the...

Alm. Brand A/S previously announced a share buy-back program of up to DKK 835.2 million under EU Safe Harbour regulations and now holds 42,210,970 own shares, equal to 2.91% of its outstanding share capital. This sizeable buy-back signals a clear focus on capital return, which may influence how investors view Alm. Brand’s balance between growth and distributions. We’ll now examine how this sizeable buy-back program shapes Alm. Brand’s existing investment narrative around capital allocation...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

To the annoyance of some shareholders, cBrain A/S ( CPH:CBRAIN ) shares are down a considerable 26% in the last month...

SP Group A/S ( CPH:SPG ) shares have continued their recent momentum with a 26% gain in the last month alone. The last...

A.P. Møller - Mærsk has appointed Ditlev Blicher as Regional President for North America and reassigned Charles van der Steene to lead the India, Middle East and Africa region, with both leadership changes effective from January 1, 2026. The reshuffle places executives with deep experience in Asia-Pacific and prior IMEA operations into two of Maersk’s most operationally complex growth regions, potentially influencing how its integrated logistics model is executed on the ground. We’ll now...

Novo Nordisk (CPSE:NOVO B) is in focus after the U.S. launch of its FDA approved Wegovy pill, the first oral GLP-1 for chronic weight management. The product is quickly rolling out across major retail and telehealth channels. See our latest analysis for Novo Nordisk. Investors appear to be reacting to the Wegovy pill launch and rapid distribution agreements, with a 30 day share price return of 18.78% and a year to date share price return of 15.50%. The 1 year total shareholder return of a...

With a price-to-earnings (or "P/E") ratio of 41.9x DSV A/S ( CPH:DSV ) may be sending very bearish signals at the...

Pandora (CPSE:PNDORA) cut its 2025 sales growth forecast to 6% after weaker than expected US holiday spending, while shares dropped 10% as the new CEO highlighted soft North American sentiment and rising silver costs. See our latest analysis for Pandora. The 13% one day share price decline and 26.3% 90 day share price return, together with a 55% drop in one year total shareholder return, suggest momentum has been fading even though three and five year total shareholder returns remain...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Why TORM’s governance reset matters for shareholders TORM (CPSE:TRMD A) has just gone through a governance reset after Oaktree Capital Management’s stake fell below one third, removing special voting rights and putting the company on a simpler one share, one vote footing. The move also coincides with Deputy Chairman and Senior Independent Director David Weinstein stepping off the Board and shifting into a Special Advisor role. This keeps his experience connected to the company while formal...

You may be wondering if Pandora is starting to look like value after a tough run, or if the risks still outweigh the potential reward for you as a shareholder or watchlist follower. The stock last closed at DKK 588.4, after a 15.4% decline over 7 days, a 16.8% decline over 30 days, a 15.4% decline year to date and a 55.0% decline over the past year, while the 3 year and 5 year returns sit at 10.7% and 6.8% respectively. Recent price moves have come alongside ongoing market attention on...

Matas A/S ( CPH:MATAS ) shareholders might be concerned after seeing the share price drop 16% in the last quarter. But...

With a price-to-earnings (or "P/E") ratio of 12.7x Rockwool A/S ( CPH:ROCK B ) may be sending bullish signals at the...

Carlsberg (CPSE:CARL B) is back in focus after its Swiss subsidiary, Feldschlösschen, temporarily stopped deliveries to Migros Group due to a pricing dispute. This has disrupted beer and soft drink supply across several Swiss retail chains. See our latest analysis for Carlsberg. Carlsberg’s pricing stand off in Switzerland comes against a backdrop of solid recent momentum, with an 11.7% 90 day share price return and a 26.05% 1 year total shareholder return, while longer term gains have been...

In February 2025, Pandora launched an EU-compliant share buyback programme and, by 2 January 2026, had repurchased shares totalling DKK 4.00 billion to reduce share capital and meet incentive scheme obligations. This sizeable capital return and reduction in share count may influence how investors assess Pandora’s earnings profile and capital allocation priorities. We’ll now explore how the completed DKK 4.00 billion buyback, and its impact on share count, reshapes Pandora’s broader...

Key Insights Significant control over UIE by private companies implies that the general public has more power to...

TORM plc recently confirmed that Oaktree Capital Management’s ownership has fallen below the one-third threshold, extinguishing the B-Director role, prompting Deputy Chairman and Senior Independent Director David Weinstein to leave the Board on January 6, 2026, while staying on as Special Advisor. Alongside this, TORM is redeeming and cancelling its B- and C-shares, simplifying its capital structure and consolidating voting power into 101,332,707 A-shares and a single remaining B-share until...

Genmab (CPSE:GMAB) recently announced a collaboration with Anthropic to deploy Claude powered AI agents across its research and development operations. The initiative aims to speed up data handling, analysis and documentation in support of key clinical programs. See our latest analysis for Genmab. The Anthropic deal lands after a busy few months for Genmab, which has included refocusing its late stage pipeline by discontinuing acasunlimab, reaffirming 2025 guidance and preparing an update at...

Ørsted (CPSE:ORSTED) is back in focus after it launched legal challenges against the US suspension of its Revolution Wind and Sunrise Wind projects, putting multi billion dollar investments and timelines under scrutiny for shareholders. See our latest analysis for Ørsted. Despite the legal overhang in the US, Ørsted’s recent price action has been mixed, with an 8.9% 7 day share price return and a 23.1% decline in 1 year total shareholder return. This suggests short term momentum alongside a...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights Bang & Olufsen's significant retail investors ownership suggests that the key decisions are influenced by...